Abstract: A safety thrombectomy device, comprising: a handle (1); a hollow outer tube (2); a hollow inner core tube (3) having a first inner core segment located in a through hole in the outer tube (2), a second inner core segment extending from the front end of the outer tube (2), and a third inner core segment extending from the rear end of the outer tube (2); a thrombus crusher (5) provided at the front end of the outer tube (2); a thrombus collector (4) connected to the front end of the second inner core segment of the hollow inner core tube (3) and located in front of the thrombus crusher (5); a tee joint (6) provided at the front end of the handle (1) and having a free end (10) used for injecting normal saline; an adjusting knob (7) provided on the handle (1) and capable of moving with respect to the handle (1) to drive the outer tube (2) to move back and forth; a locking knob (8) provided on the handle (1) and used for locking the adjusting knob (7) after the outer tube (2) moves to a preset position; and an inj

Abstract: A Z-shaped braided stent capable of being implanted into a human organ. The Z-shaped braided stent comprises: a first tubular wire mesh having N braided rings and formed by continuously braiding first braid wires (I) in a Z shape, each braided ring of the first tubular wire mesh having a plurality of first bending points (A) formed by bending the first braid wires (I) and distributed at intervals; and a second tubular wire mesh having N braided rings and formed by continuously braiding second braid wires (II) in a Z shape, each braided ring of the second tubular wire mesh having a plurality of second bending points (B) formed by bending the second braid wires (II) and distributed at intervals. By hooking the first bending points (A) with the second bending points (B), the second tubular wire mesh and the first tubular wire mesh are connected together to form the Z-shaped braided stent. The braided stent can be subjected to axially deformable compression, but axially basically non-deformable stretching.

Abstract: The present disclosure provides use of fructose in preparing a drug for treating a cerebral ischemic stroke, and relates to the technical field of biomedicine. In the present disclosure, an ischemic injury cell model and an ischemic injury animal model are established, and fructose treatment is conducted on the injury models; and it is found that the fructose can regulate energy metabolism and redox metabolism of neurons, and reduce an ischemic injury of model cells and model animals. Specifically, the present disclosure includes: reducing a neuronal mortality after the ischemic injury, reducing an area of cerebral infarction in animals with the ischemic injury, and improving neurobehavioral characteristics of the animals.

Abstract: A specific antibody for detecting the blood brain barrier early injury of cerebral ischemic stroke is characterized by specifically identifying specifically identifying DHYETDYTTGGESC in degradation fragments of an occludin protein, but not identify ing the full-length occludin protein. Therefore, the antibody can be used for specifically detecting the blood brain barrier early injury of the cerebral ischemic stroke, and can eliminate the influence of the full-length occludin protein in serum on a detection result, so that the specificity and accuracy of detecting the blood brain barrier early injury of the cerebral ischemic stroke are significantly improved.

Abstract: A specific antibody for detecting the blood brain barrier early injury of cerebral ischemic stroke is characterized by specifically identifying KTRRKMDRYDKSNIL in degradation fragments of an occludin protein, but not identifying the full-length occludin protein. Therefore, the antibody can be used for specifically detecting the blood brain barrier early injury of the cerebral ischemic stroke, and can eliminate the influence of the full-length occludin protein in serum on a detection result, so that the specificity and accuracy of detecting the blood brain barrier early injury of the cerebral ischemic stroke are obviously improved.

Abstract: The present disclosure provides use of fructose in preparing a drug for treating a cerebral ischemic stroke, and relates to the technical field of biomedicine. In the present disclosure, an ischemic injury cell model and an ischemic injury animal model are established, and fructose treatment is conducted on the injury models; and it is found that the fructose can regulate energy metabolism and redox metabolism of neurons, and reduce an ischemic injury of model cells and model animals. Specifically, the present disclosure includes: reducing a neuronal mortality after the ischemic injury, reducing an area of cerebral infarction in animals with the ischemic injury, and improving neurobehavioral characteristics of the animals.

Abstract: A specific antibody for detecting the blood brain barrier early injury of cerebral ischemic stroke is characterized by specifically identifying KTRRKMDRYDKSNIL in degradation fragments of an occludin protein, but not identifying the full-length occludin protein. Therefore, the antibody can be used for specifically detecting the blood brain barrier early injury of the cerebral ischemic stroke, and can eliminate the influence of the full-length occludin protein in serum on a detection result, so that the specificity and accuracy of detecting the blood brain barrier early injury of the cerebral ischemic stroke are obviously improved.

Abstract: A specific antibody for detecting the blood brain barrier early injury of cerebral ischemic stroke is characterized by specifically identifying specifically identifying DHYETDYTTGGESC in degradation fragments of an occludin protein, but not identifying the full-length occludin protein. Therefore, the antibody can be used for specifically detecting the blood brain barrier early injury of the cerebral ischemic stroke, and can eliminate the influence of the full-length occludin protein in serum on a detection result, so that the specificity and accuracy of detecting the blood brain barrier early injury of the cerebral ischemic stroke are significantly improved.

Abstract: A specific antibody for detecting the blood brain barrier early injury of cerebral ischemic stroke is characterized by only specifically identifying SKLSHIKKMVGDYDR in degradation fragments of an occludin protein, but not identifying the full-length occludin protein. Therefore, the antibody can be used for specifically detecting the blood brain barrier early injury of the cerebral ischemic stroke, and can eliminate the influence of the full-length occludin protein in serum on a detection result, so that the specificity and accuracy of detecting the blood brain barrier early injury of the cerebral ischemic stroke are obviously improved.

Abstract: Disclosed is ischemic precondition treatment equipment and a use and method thereof for judging health condition of blood vessels. A gas way structure (4) is arranged inside a shell of ischemic precondition training treatment equipment. The gas way structure comprises a 5-way device (43). The 5-way device (43) is connected to a left gas pump (41), a right gas pump (42), a left solenoid valve (44), a right solenoid valve (45) and a release valve (48), respectively. The gas way structure (4) can rapidly bring a pressure of an armband airbag to the set pressure value in a short period of time, which is effective in relieving the patients' discomfort and pain when used. It is suitable for long-term use for training. In addition, it also can judge the health condition of blood vessels.

Abstract: Disclosed is ischemic precondition treatment equipment and a use and method thereof for judging health condition of blood vessels. A gas way structure (4) is arranged inside a shell of ischemic precondition training treatment equipment. The gas way structure comprises a 5-way device (43). The 5-way device (43) is connected to a left gas pump (41), a right gas pump (42), a left solenoid valve (44), a right solenoid valve (45) and a release valve (48), respectively. The gas way structure (4) can rapidly bring a pressure of an armband airbag to the set pressure value in a short period of time, which is effective in relieving the patients' discomfort and pain when used. It is suitable for long-term use for training. In addition, it also can judge the health condition of blood vessels.

Abstract: In various embodiments, the present invention teaches systems and methods for using T1-weighted black-blood MR imaging, with which a CVT can be well isolated from the surrounding tissues due to the signal suppression of flowing blood. In some embodiments, the invention teaches using black-blood imaging (3D variable-flip-angle turbo spin-echo acquisition) to directly visualize thrombi. In certain embodiments, the invention teaches using T1 weighted image contrast and isotropic sub-millimeter spatial resolution for accurate detection and staging of thrombi. In various embodiments, the invention allows for the detection of chronic thrombosis recanalization.